文献速递免疫规划慢病防控与筛查

血液透析患者中吲哚胺2,3-双加氧酶、干扰素-λ3与抗-HBs抗体的相关性

Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients.
PubMed 文献 · Vaccine · 2018-06-20

研究纳入1022例已明确乙肝疫苗应答状态的血液透析患者和315例暴露于HBV的患者,分析IDO1、IFNL4基因多态性与抗-HBs产生及生存的关系。IDO1多态性与抗-HBs产生无关,但rs9657182、rs8099917、rs12979860间存在对抗-HBs滴度的上位性交互作用(P=0.028);抗-HBs滴度与血浆IDO负相关(r=-0.358,P=0.006),与IFN-λ3正相关(r=0.498,P=0.00008);

要点

  • IDO1 rs9657182、IFNL4 rs8099917与rs12979860之间存在对抗-HBs滴度的上位性交互作用(P=0.028)。
  • 抗-HBs滴度与血浆IDO负相关(r=-0.358,P=0.006),与循环IFN-λ3正相关(r=0.498,P=0.00008)。

核心结论

  • IDO1 rs9657182、IFNL4 rs8099917与rs12979860对抗-HBs滴度存在上位性交互作用。
  • 对HBsAg的过度免疫应答见于IDO较低但IFN-λ3较高的患者。
  • rs9657182 TT基因型与血液透析患者感染相关死亡相关。

研究设计与样本

  • 研究纳入已明确乙肝疫苗应答状态的血液透析患者(n=1022)及暴露于HBV的患者(n=315)。
  • 采用高分辨率熔解曲线分析对IDO1 rs3739319 A<G、rs9657182 C<T及IFNL4 rs8099917 G<T、rs12979860 C>T进行基因分型。
  • 对57名受试者采用ELISA检测循环IDO与IFN-λ3。
  • 采用Kaplan-Meier法分析生存概率。

主要发现

  • IDO1 SNPs与疫苗接种或感染后产生抗-HBs的能力无关。
  • 抗-HBs滴度(包括抗-HBs≥1000 IU/L的频率)与IDO1 SNPs无关联,但rs9657182、rs8099917与rs12979860间对抗-HBs滴度存在上位性交互作用(P=0.028)。
  • 未证实IDO1 SNPs与循环IDO之间存在显著关联。
  • 抗-HBs滴度与血浆IDO负相关(r=-0.358,P=0.006),与循环IFN-λ3正相关(r=0.498,P=0.00008)。

关键数值与推荐

  • 疫苗接种或感染后抗-HBs超过10 IU/L诊断为具备产生抗-HBs的能力。
  • 上位性交互作用对抗-HBs滴度的P=0.028。
  • 抗-HBs滴度与血浆IDO的相关系数r=-0.358(P=0.006)。
  • 抗-HBs滴度与循环IFN-λ3的相关系数r=0.498(P=0.00008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) contributes to maintaining immune homeostasis. Polymorphisms (SNPs) of the IDO encoding gene (IDO1) influence the IDO activity. Interferon (IFN)-λ3 induces IDO expression. We aimed to investigate whether IDO1 variants are associated with anti-HBs production in response to HBV vaccination or infection, interact with IFN-λ3 associated variants of IFNL4, and influence survival of hemodialysis (HD) patients. We also tested circulating IDO concerning IDO1 SNPs and plasma IFN-λ3 and anti-HBs levels. METHODS: The study included HD patients who had established status concerning responsiveness to HBV vaccination (n = 1022) or were exposed to HBV (n = 315). Ability to generate anti-HBs was diagnosed if anti-HBs after vaccination or infection exceeded 10 IU/L. Genotyping of IDO1 (rs3739319 A < G, rs9657182 C < T), IFNL4 rs8099917 G < T and IFNL4 rs12979860 C > T polymorphisms was carried out by high-resolution melting curve analysis. Circulating IDO and IFN-λ3 were measured with ELISA in 57 subjects. Survival probability was analyzed using the Kaplan-Meier method. RESULTS: IDO1 SNPs did not correlate with the ability to produce anti-HBs after vaccination or infection. Anti-HBs titers, including a frequency of anti-HBs ≥ 1000 IU/l, also did not associate with IDO1 SNPs, but there was an epistatic interaction between rs9657182, rs8099917, and rs12979860 concerning anti-HBs titers (P = 0.028). Significant associations between IDO1 SNPs and circulating IDO were not demonstrated. Anti-HBs titers negatively correlated with plasma IDO (r = -0.358, P = 0.006), and positively with circulating IFN-λ3 (r = 0.498, P = 0.00008). IDO and IFN-λ3 did not correlate. Patients possessing the rs9657182 TT genotype showed higher infection-related mortality, also in multivariate analysis (HR 2.073, 1.221-3.518, P = 0.007). CONCLUSIONS: IDO1 rs9657182, IFNL4 rs8099917, and IFNL4 rs12979860 show epistatic interaction concerning anti-HBs titers. Overreacting immune responses to HBsAg occur in patients with lower IDO but simultaneously higher IFN-λ3 levels. The rs9657182 TT genotype associates with infection-related mortality of HD patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Grzegorzewska AE, Winnicka H, Warchoł W, et al. Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients. Vaccine. 2018. PMID: 29935858. doi:10.1016/j.vaccine.2018.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。